BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Atherosclerosis |
📓
Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model? Clinical and diagnostic laboratory immunology (Clin Diagn Lab Immunol ) Vol: 6 Issue 6 Pages: 891-4 Pub: 1999 Nov Epub: Authors Fong IW , Chiu B , Viira E , Jang D , Fong MW , Peeling R , Mahony JB , Html Article Publication |
| Atherosclerosis |
📓
Implications of Porphyromonas gingivalis peptidyl arginine deiminase and gingipain R in human health and diseases. Frontiers in cellular and infection microbiology (Front Cell Infect Microbiol ) Vol: 12 Issue Pages: 987683 Pub: 2022 Epub: 2022 Sep 29 Authors Chow YC , Yam HC , Gunasekaran B , Lai WY , Wo WY , Agarwal T , Ong YY , Cheong SL , Tan SA , Html Article Publication |
| Atherosclerosis |
📓
Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome. Frontiers in physiology (Front Physiol ) Vol: 12 Issue Pages: 645212 Pub: 2021 Epub: 2021 May 24 Authors Ji L , Chen S , Gu G , Zhou J , Wang W , Ren J , Wu J , Yang D , Zheng Y , Html Article Publication |
| Atherosclerosis |
📓
Proteus mirabilis Targets Atherosclerosis Plaques in Human Coronary Arteries via DC-SIGN (CD209). Frontiers in immunology (Front Immunol ) Vol: 11 Issue Pages: 579010 Pub: 2020 Epub: 2021 Jan 8 Authors Xue Y , Li Q , Park CG , Klena JD , Anisimov AP , Sun Z , Wei X , Chen T , Html Article Publication |
| Atherosclerosis |
📓
Deficiency of Nucleotide-binding oligomerization domain-containing proteins (NOD) 1 and 2 reduces atherosclerosis. Basic research in cardiology (Basic Res Cardiol ) Vol: 115 Issue 4 Pages: 47 Pub: 2020 Jun 25 Epub: 2020 Jun 25 Authors Vlacil AK , Schuett J , Ruppert V , Soufi M , Oberoi R , Shahin K , Wächter C , Tschernig T , Lei Y , Liu F , Tietge UJF , Schieffer B , Schuett H , Grote K , Html Article Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
